Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Weill Medical College of Cornell University
Weill Medical College of Cornell University
Mayo Clinic
Peking University People's Hospital
Memorial Sloan Kettering Cancer Center
Columbia University
Memorial Sloan Kettering Cancer Center
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Hadassah Medical Organization
Fondazione IRCCS Policlinico San Matteo di Pavia
Peking University People's Hospital
University of Tennessee Graduate School of Medicine
Peking University People's Hospital
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
The Cleveland Clinic
Boston Medical Center
Barbara Ann Karmanos Cancer Institute
University of Iowa
Peking Union Medical College Hospital
Medical College of Wisconsin
Boston Medical Center
M.D. Anderson Cancer Center
Fondazione IRCCS Policlinico San Matteo di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia
Boston University
Boston Medical Center
PETHEMA Foundation
Boston Medical Center
Boston Medical Center
Mayo Clinic
Boston Medical Center
Boston Medical Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Heidelberg University
Mayo Clinic
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
Hoag Memorial Hospital Presbyterian
Temple University
Fred Hutchinson Cancer Center